Skip to main content
Inner Mongolia Furui Medical Science Co.,Ltd. logo

Inner Mongolia Furui Medical Science Co.,Ltd. — Investor Relations & Filings

Ticker · 300049 ISIN · CNE100000KG1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,747 across all filing types
Latest filing 2026-05-25 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300049

About Inner Mongolia Furui Medical Science Co.,Ltd.

https://www.fu-rui.com

Inner Mongolia Furui Medical Science Co.,Ltd. specializes in the integrated diagnosis and treatment of chronic liver diseases. The company operates through a business model that combines medical diagnostics, pharmaceuticals, and healthcare services. A core component of its portfolio is the FibroScan technology, managed by its subsidiary Echosens, which provides non-invasive solutions for assessing liver stiffness and steatosis. In the pharmaceutical sector, the company produces Fuzheng Huayu, a proprietary medication used for the treatment of liver fibrosis. Furui Medical focuses on the development of digital health platforms and standardized diagnosis and treatment systems to improve patient outcomes in hepatology. By leveraging its diagnostic tools and therapeutic products, the company provides comprehensive management solutions for conditions such as non-alcoholic fatty liver disease (NAFLD) and viral hepatitis.

Recent filings

Filing Released Lang Actions
关于与专业投资机构共同投资基金的进展公告
Capital/Financing Update Classification · 83% confidence The document is a progress announcement concerning the company’s co-investment in a private equity fund, detailing LP changes, registration, and fund filing. There are no financial statements or earnings figures. It falls under updates on financing activities/capital deployment rather than a regulatory certification or full report. This matches the “Capital/Financing Update (CAP)” category.
2026-05-25 Chinese
关于参加内蒙古辖区上市公司2026年投资者网上集体接待日活动的公告
Regulatory Filings Classification · 85% confidence The document is a brief company announcement to investors and regulators about the company’s participation in an online investor reception day. It does not contain financial results, presentations, or report attachments/details. It is a general regulatory announcement of an upcoming event, fitting the fallback Regulatory Filings category (RNS).
2026-05-25 Chinese
福瑞医科：北京市嘉源律师事务所关于内蒙古福瑞医疗科技股份有限公司2025年年度股东会的法律意见书
AGM Information Classification · 85% confidence The document is a formal legal opinion (“法律意见书”) issued by a law firm regarding Inner Mongolia Furuimedical Technology Co., Ltd.’s 2025 Annual General Meeting, covering the convening procedures, attendees, voting process and results. It is part of the official AGM materials, not the company’s financial statements or an earnings announcement. Hence it falls under AGM Information (materials shared during the AGM).
2026-05-13 Chinese
福瑞医科：第九届董事会第一次会议决议公告
Board/Management Information Classification · 91% confidence The document is an official announcement of resolutions from the ninth board of directors’ first meeting, including the election of a new board chairman, formation of board committees, and extension of senior management appointments. This clearly pertains to changes in the company’s board and senior management structure, matching the Board/Management Information category.
2026-05-13 Chinese
福瑞医科：关于完成董事会换届选举暨延期聘任高级管理人员及证券事务代表的公告
Board/Management Information Classification · 90% confidence The document is a regulatory announcement by a listed company describing the completion of its board of directors election (the ninth board), committee compositions, and the extension of current senior management and securities affairs representative appointments. It contains no financial data or investor presentation materials, but rather details changes in the board and management structure. This clearly corresponds to the Board/Management Information category.
2026-05-13 Chinese
福瑞医科：2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2025 Annual General Meeting, detailing each proposal and the voting results (total and by minority shareholders) and legal opinion. It is not a report of the meeting materials, nor is it a proxy statement; it specifically provides the official results of shareholder votes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-13 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.